Whilst O’Donnell laudably tried to target the audience’s attention onand hopefully very last, Charlie Sheen trainwreck interview, courtesy of the tragic undertow that threatens to pull Sheen below for superior, I used to be overtaken, not through the pulling on the thread, and then the voracious audience he serves. It didn’t make me depressing, it made me angry.
With regards to celebrities, we are able to be considered a heartless region, basking in their misfortunes like nude sunbathers at Schadenfreude Beach. The impulse is understandable, to some diploma. It may be grating to listen to complaints from individuals who take pleasure in privileges that many of us cannot even consider. When you cannot muster up some compassion for Charlie Sheen, who helps make a lot more funds for a day’s perform than most of us will make inside a decade’s time, I guess I can not blame you.
With all the fast tempo of events on the net and also the information revolution sparked through the On-line, it is particularly effortless for the technologies trade to feel it’s different: often breaking new ground and accomplishing points that no one has actually carried out earlier than.
But you will discover other types of business enterprise which have already undergone a lot of the same radical shifts, and have just as excellent a stake inside long run.
Get healthcare, for example.
We often presume of it as being a massive, lumbering beast, but in truth, medicine has undergone a sequence of revolutions inside the previous 200 years which might be at least equal to all those we see in technologies and facts.
Less understandable, but nonetheless inside of the norms of human nature, may be the impulse to rubberneck, to slow down and check out the carnage of Charlie spectacle of Sheen’s unraveling, but on the blithe interviewer Sheen’s life as we pass it from the perfect lane of our each day lives. To be sincere, it may be tough for men and women to discern the difference involving a run-of-the-mill interest whore, and an honest-to-goodness, circling the drain tragedy-to-be. On its very own merits, a quote like “I Am On a Drug. It’s Identified as Charlie Sheen” is sheer genius, and we can not all be expected to take the complete measure of someone’s everyday living each and every time we listen to a little something funny.
Speedy forward to 2011 and I am wanting to investigate implies of becoming a bit more business-like about my hobbies (mostly new music). Through the conclude of January I had manned up and started off to advertise my blogs. I had developed various several blogs, which were contributed to by acquaintances and colleagues. I promoted these activities as a result of Facebook and Twitter.
2nd: the tiny abomination that the Gang of 5 around the Supream Court gave us a year or so in the past (Citizens Inebriated) in fact comprises slightly bouncing betty of its own that may pretty properly go off from the faces of Govs Wanker, Sacitch, Krysty, and J.O. Daniels. Considering this ruling extended the principle of “personhood” to both businesses and unions, to check out to deny them any best suited to run within the legal framework that they were organized below deprives these “persons” from the freedoms of speech, association and motion. Which means (after yet again, quoting law college educated relatives) that possibly the courts ought to uphold these rights for the unions (as particular person “persons” as guaranteed from the Federal (and most state) constitutions, or they have to declare that these attempts at stripping or limiting union rights really have to apply to serious corporations, also.
With the rapid pace of events on the web and the information revolution sparked by the Internet, it’s very easy for the technology industry to think it’s unique: constantly breaking new ground and doing things that nobody has ever done before.
But there are other sorts of business that have already undergone some of the same radical shifts, and have just as great a stake in the future.
Take healthcare, for instance.
We often think of it as a huge, lumbering beast, but in truth, medicine has undergone a series of revolutions in the past 200 years that are at least equal to those we see in technology and information.
The first stirrings of modern chemistry and biology were only just beginning in the 19th century, but by 1967, Christiaan Barnard started transplanting hearts. Similarly, it was only in the 1950s Watson and Crick discovered DNA. Less than 50 years later, the first draft of the human genome was produced. If that’s not rapid, world-shattering change, then what is?
Pharma has also faced other challenges the web industry is only now starting to realize. Products are slow to make, and drugs can take years to design, test and manufacture. Accordingly, R&D spending in pharmaceuticals is very high overall; according to the European Union (PDF), five of the world’s top 10 companies by R&D spend are in drugs or biotechnology (among traditional technology companies, only Microsoft, Nokia and Samsung feature in the list). And it’s a far greater proportion of total turnover (Pfizer spends around one seventh of revenues on research, Apple spends around one dollar on R&D for every 13 it brings in).
And where the planet’s electronics giants spend billions attempting to end piracy and patent infringement, pharmaceutical companies are rapidly adjusting to the fact that they only get 12 years before patent protection ends and other companies can introduce generic drugs. Imagine a situation where Windows 98 was already old enough to be forcibly open-sourced, and you get the idea of how disruptive that might be.
So, what does the pharmaceutical industry have to teach us?
First, be careful. Your property and ideas won’t be yours for long.
Second, while new discoveries are important, revolutions can be reliably predicted, most of the time. From the outside, Barnard’s transplants were a radical shift in surgery. From inside the profession, it was the next obvious step after previous organ transplants.
Third, the way money is being spent will inevitably change. It’s already happening: an issue addressed by the latest VC bulletin from Go4Venture, a London-based advisory group for European entrepreneurs and investors (you can sign up here). Their latest dispatch outlines the state of deal-making in Europe (more of them, but less valuable, as reflected in figures we wrote about last month), and they also point out Europe’s technology financing system is undergoing a significant shift:
[there is a] major structural change in European venture capital financing where corporates will play a more prominent role going forward. Corporates are facing a lasting ex-growth market environment (courtesy of debt-laden Western economies) and realise that internal R&D is rather expensive and just cannot cover the whole front of innovation.
For corporates, investing in start-ups has the added advantage of encouraging a more entrepreneurial culture inside and creating a stream of acquisition opportunities.
Pharma has been there before, in an early move precipitated by proprietary drugs coming off patent, and we are now seeing the pharma model spreading to other IP-driven sectors.
Spending more of the R&D budget on other companies doesn’t just mean acquisition, of course — although the startup world is very familiar with the process and it’s clearly the most common option. Just yesterday, Google spent $60 million making the slightly odd move to buy British price comparison website BeatThatQuote. It could also mean more early investment in small companies, like the $100,000 Microsoft is putting into Moscow-based anti-piracy startup Pirate Pay.
But what it does mean is, ultimately, the growth in the number of deals we’re seeing is going to get faster, and there will be more opportunities for innovative startups and smart entrepreneurs. Twinned with the aggressive, high valuation investing strategy of a company like Russia’s Digital Sky Technologies, it seems more likely than not we’ll see things explode, in Europe and elsewhere, over the next year or two.
Related content from GigaOM Pro (subscription req’d):
- A 2011 NewNet Forecast
- A 2011 Mobile Forecast
- A 2011 Connected Consumer Forecast
This was supposed to be an article about monetizing your life as an amateur musician. It’s become an opinion piece on my experience of Google AdSense.
Google Adsense allows you receive revenue through placing content-specific adverts on your website. The system makes Google around $8 Billion a year.
I signed up for Adsense several years ago. I had a travel blog which was general only for family and friends. If I remember correctly, my travel blog made me about £0.05 across 2 years or so.
Fast forward to 2011 and I am trying to investigate means of being a little more business-like about my hobbies (mostly music). By the end of January I had manned up and started to promote my blogs. I had created several different blogs, which were contributed to by friends and colleagues. I promoted these activities through Facebook and Twitter.
After a few weeks, I was looking at around 2,000 hits a month across all my content sources. I was feeling pretty proud of myself. My Google Adsense balance was approaching £10, and I hoped I could make around £50-100 a year. Google then disabled my account.
When your Adsense account is disabled you receive a standard email which tells you there has been "invalid activity". It directs you to a help URL. The only response you can take is to make an appeal.
Taking the matter particularly seriously, I spent some time writing the appeal which outlined my thoughts on the invalid activity. My guess is that I have violated their "don’t click on your own ads" policy when I’ve been proudly showing off my sites to friends and family. Since my IP address is logged on Blogger etc. and my clicks are less than 1% of the total hits received from countries far and wide, I assumed that they would realise my site was genuine.
Continued on the next pageSource: http://removeripoffreports.net/ corporate Reputation Management
The best in online reputation management
No comments:
Post a Comment